Multiple Myeloma Treatment Market - Global Market Size, Share, Trend, Market Growth, Analysis And Industry Forecasts to 2025

The latest market report published by Credence Research, Inc. “Global Multiple Myeloma Treatment Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2017 - 2025,” the Multiple Myeloma Treatment market was valued at USD 8,398.3 Mn in 2016, and is expected to reach USD 21,221.8 Mn by 2025, expanding at a CAGR of 11.0% from 2017 to 2025.
Market Insights
Multiple myeloma treatment options have developed significantly over the last decade. Novel multiple myeloma treatments have provided efficient survival rates among myeloma patients. It has been also observed that the upcoming drug pipeline of multiple myeloma is promising, biological drugs and stem cell based therapies are expected to drive the market in the near future. The key players operating in this industry are accelerating the research and development activities for future multiple myeloma treatment, but by customizing treatments based on a patient’s genome.
Browse the full report Multiple Myeloma Treatment Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2017 – 2025 at http://www.credenceresearch.com/report/multiple-myeloma-treatment-market
According to Multiple Myeloma Research Foundation, multiple myeloma typically occurs in bone marrow specifically located in the spine, pelvic bones, ribs, and area of the shoulders and hips. Moreover, groups of myeloma cells force other cells in the bone marrow to remove the solid part of the bone and cause osteolytic lesions or soft spots in the bone, resulting in weakened bones and increasing the risk of fractures.
In year 2016, drugs therapy is expected to be the largest market due to key driving factors such as most convenient mode of treatment, rising demand for non-invasive treatments, and incessant development in research and development activities are expected to bring target specific drug therapies. During forecast period 2017 – 2025, stem cell transplantation therapies segment is expected to be the fastest growing segments as approved personalized cellular therapy for advanced leukemia named chimeric antigen receptor (CAR) T-cell therapy is under clinical trials for multiple myeloma and its approval is expected to boost the growth of multiple myeloma treatment market in the near future.
North America accounted for the largest share in global multiple myeloma treatment market due to key driving factors such as rising prevalence of multiple myeloma, high awareness associated with early cancer diagnosis and treatment, supportive reimbursement policies, and developed healthcare infrastructure. During the forecast period Asia Pacific is expected to project exponential growth due to rising awareness associated with the early cancer diagnosis, and developing healthcare infrastructure is responsible of high accessibility to modern technology.
Market Competition Assessment:
The multiple myeloma treatment market is observed as the most diversified and competitive market comprising large number of players.  The market is dominated by several players, depending on their major competencies. The key players in this market are Celgene Corporation, Janssen Biotech, Inc., Bristol-Myers Squibb Company, Novartis AG, Millennium Pharmaceuticals, Amgen, Inc., Genzyme Corporation, Juno Therapeutics, among others.
Key Market Movements:
  • Rising prevalence of multiple myeloma in developing countries is assisting the growth of drug therapy
  • Recent launch of launch of monoclonal antibodies (mAbs) Empliciti and daratumumab along with strong pipeline
  • High awareness associated with early cancer diagnosis and availability of advanced diagnostic techniques such as imaging devices and personalized diagnostic tests
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist works straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
Ph: 1-800-361-8290

Comments

Post a Comment

Popular posts from this blog

Global Emu Oil Market Analysis and Forecast 2017- 2025 - Credence Research

According to a new market report published by Credence Research “ Emu Oil Market  Growth, Future Prospects and Competitive Analysis, 2016 – 2024,” the global emu oil market is expected to reach over US$ 154.05 Mn by 2024, expanding at a CAGR of 5.6% from 2016 to 2024. Market Insights The global emu oil market is progressing at a considerable pace and is anticipated to attain significant market size over the next few years. Emu oil is manufactured using natural product from emu bird, and is widely used in various applications such as skin care, face care, hair care, medical and others. The global emu oil market was valued at US$ 94.34 Mn in 2015, and is expected to reach US$ 154.05 Mn by 2024, expanding at a CAGR of 5.6% from 2016 to 2024. Browse the full Emu Oil Market - Market Growth, Future Prospects and Competitive Analysis, 2016 – 2024 report at  http://www.credenceresearch.com/report/emu-oil-market The market is witnessing growth due to rise in consumer awareness regardi
Read more

E-commerce Logistics Market: Global Industry Analysis and Opportunity Assessment, 2017-2025

According to a new market report published by Credence Research, Inc., “ E-commerce Logistics Market Size  (By Operational Area (International (Cross-border) and Domestic), By Service Type (Transportation, Warehousing, and Other Services), By Geography (North America, Europe, Asia Pacific, and Rest of the World)) – Growth, Share, Opportunities, Competitive Analysis, and Forecast 2015 – 2025” the global e-commerce logistics market is expected to grow at a CAGR of 19.5% during the forecast period 2015 – 2025. Browse the full E-commerce Logistics Market- Growth, Share, Opportunities, Competitive Analysis, and Forecast 2015 – 2025 report at  http://www.credenceresearch.com/report/e-commerce-market Market Insights Logistics has become an integral component of an e-commerce business as it is responsible for planning, control and flow of products from the point of origin to end-consumers. The proliferation of the e-commerce sector and consequent rise in cross-border (international) e-
Read more

Acquired Hemophilia Treatment Market Opportunities, Trends, Size And Market Share 2017 - 2025 - Credence Research

​ The latest market report published by Credence Research, Inc. “Global  Acquired Hemophilia Treatment Market  - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2023,” the acquired hemophilia treatment market was valued at USD 1,923.4 Mn in 2015, and is expected to reach USD 2,474.7 Mn by 2023, expanding at a CAGR of 3.2% from 2016 to 2023. Market Insights According to National Organization of Rare Disorders (NORD), acquired hemophilia is a rare autoimmune disorder characterized by bleeding that occurs in patients with a personal and family history negative for hemorrhages. In acquired hemophilia, the body produces antibodies that attack clotting factors, most often factor VIII. Medical practitioners suggest that, acquired hemophilia can potentially cause life-threatening bleeding complications in severe cases and in around 50% of cases, there is an identifiable underlying clinical condition; in the other 50% no cause is known i.e. idiopathic. Browse th
Read more